KR880013565A - 네리움(Nerium)종의 추출물 및 그것을 이용한 세포-분열 증식 질병의 치료방법 - Google Patents
네리움(Nerium)종의 추출물 및 그것을 이용한 세포-분열 증식 질병의 치료방법 Download PDFInfo
- Publication number
- KR880013565A KR880013565A KR1019870006798A KR870006798A KR880013565A KR 880013565 A KR880013565 A KR 880013565A KR 1019870006798 A KR1019870006798 A KR 1019870006798A KR 870006798 A KR870006798 A KR 870006798A KR 880013565 A KR880013565 A KR 880013565A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- nerium
- heating
- solvent
- plant material
- Prior art date
Links
- 239000000284 extract Substances 0.000 title claims 21
- 238000000034 method Methods 0.000 title claims 15
- 241000893864 Nerium Species 0.000 title claims 11
- 201000010099 disease Diseases 0.000 title claims 10
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims 10
- 230000002062 proliferating effect Effects 0.000 title claims 3
- 238000010438 heat treatment Methods 0.000 claims 8
- 241000196324 Embryophyta Species 0.000 claims 7
- 239000000463 material Substances 0.000 claims 7
- 239000002904 solvent Substances 0.000 claims 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 6
- 241001465754 Metazoa Species 0.000 claims 5
- 230000003211 malignant effect Effects 0.000 claims 4
- 208000009956 adenocarcinoma Diseases 0.000 claims 2
- 210000004027 cell Anatomy 0.000 claims 2
- 238000001914 filtration Methods 0.000 claims 2
- 102000019034 Chemokines Human genes 0.000 claims 1
- 108010012236 Chemokines Proteins 0.000 claims 1
- 206010010356 Congenital anomaly Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 244000187664 Nerium oleander Species 0.000 claims 1
- 201000004681 Psoriasis Diseases 0.000 claims 1
- 230000003187 abdominal effect Effects 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 230000001413 cellular effect Effects 0.000 claims 1
- 238000001727 in vivo Methods 0.000 claims 1
- 230000002401 inhibitory effect Effects 0.000 claims 1
- 229910001867 inorganic solvent Inorganic materials 0.000 claims 1
- 239000003049 inorganic solvent Substances 0.000 claims 1
- 238000010253 intravenous injection Methods 0.000 claims 1
- 239000012528 membrane Substances 0.000 claims 1
- 210000005087 mononuclear cell Anatomy 0.000 claims 1
- 210000004165 myocardium Anatomy 0.000 claims 1
- 210000002569 neuron Anatomy 0.000 claims 1
- 238000007911 parenteral administration Methods 0.000 claims 1
- 230000001575 pathological effect Effects 0.000 claims 1
- 241000894007 species Species 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/24—Apocynaceae (Dogbane family), e.g. plumeria or periwinkle
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/415—Assays involving biological materials from specific organisms or of a specific nature from plants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Oncology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Dermatology (AREA)
- Physics & Mathematics (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Plant Substances (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (28)
- 동물의 세포-증식 질병의 치료에 유용한 네리움(Nerium)종의 추출물
- 제1항에 있어서, 상기 네리움종의 네리움 올렌더(Nerium oleander)인 것을 특징으로 하는 추출물.
- 제1항에 있어서 상기 질병이 악성인 것을 특징으로 하는 추출물.
- 제3항에 있어서, 상기 악성 질병이 선암인 것을 특징으로 하는 추출물.
- 제1항에 있어서, 상기 질병이 비 악성인 것을 특징으로 하는 추출물.
- 제5항에 있어서, 상기 비악성질병이 건선인 것을 특징으로 하는 추출물.
- 제1항에 있어서, 상기 추출물이 쥐의 선천성 암의 생체내 성장을 억제하는 것을 특징으로 하는 추출물.
- 제1항에 있어서, 상기 추출물이 실험실적 조건에서 인간의 신경당에서가 아니라, 인간의 단핵세포에서 화학일루미네센스로 유도되는 포볼에스테르 또는 지모산의 형성을 억제하는 것을 특징으로 한다.
- (a)극성의 무기 용매내에 상기의 네리움의 종으로 언급한 식물물질을 분산시키고 (b)상기의 분산된 식물물질을 가열한 후 (c)상기의 식물물질로부터 단계(b)의 가열된 용매를 분리한 다음 (d)단계(c)의 분리된 용매를 가열하여 얻어지는, 동물의 세포증식 질병을 억제하는데 유용한 네리움종의 추출물.
- 제9항에 있어서 (e)단계(d)의 가열된 용매를 여과하고 (f)단계(e)의 여과된 용매를 가열하여 얻어진 것을 특징으로 하는 추출물.
- 제9항에 있어서, 상기 용매가 물인 것을 특징으로 하는 추출물.
- 제9항에 있어서, 상기 가열이 상기 용매의 밀도가 약1010을 얻기에 충분한 시간동안 실행되는 것을 특징으로 하는 추출물.
- 제9항에 있어서, 상기 네리움종이 네리옴 올렌더인 것을 특징으로 하는 추출물.
- (a)물안에 상기의 네리움 올렌더의 식물물질을 분산시키고 (b)상기의 분산된 식물물질을 약 2.5시간동안 약 100℃에서 가열한 후 (c)상기 식물물질로부터 가열된 물을 분리하고 (d)단계(c)에서 분리된 물을 약 1010의 밀도를 갖도록 약 100℃에서 약 2.5시간동안 가열하여 얻어진, 동물의 세포 질병의 완화에 유용한 네리움 올렌더의 추출물.
- 제14항에 있어서, (e)제14항의 단계(d)에서 얻은 가열된 물을 여과하고 (f)단계(e)의 여과된 물을 약 100℃에서 약1시간동안 가열하여 얻은 것을 특징으로 하는 추출물.
- 제14항에 있어서, 상기 식물물질의 잘게 저며진 잎, 줄기, 꽃들인 것을 특징으로 하는 추출물.
- 상기의 동물에 네리움종의 추출물을 치료학상 효과적인 양만큼 투여하여 동물의 세포증식질병을 완화하는 방법.
- 제17항에 있어서 상기의 네리움종이 네리움 올렌더인 것을 특징으로 하는 방법.
- 제17항에 있어서 상기의 질병이 선암인 것을 특징으로 하는 방법.
- 제17항에 있어서, 상기의 투여가 비경구적인 투여인 것을 특징으로 하는 방법.
- 제20항에 있어서, 상기의 비경구적투여가 피하, 근육대, 복강대, 동대 또는 정맥내 주사에 의한 것이거나, 경리적, 비인강적, 또는 점막에 의한 흡수인 것을 특지으로 하는 방법.
- 제21항에 있어서, 상기의 투여량이 약 0.05ml에서 약 1.0ml인 것을 특징으로 하는 방법.
- 제21항에 있어서, 상기의 투여량이 약 0.2ml에서 약 0.9ml인 것을 특징으로 하는 방법.
- 제21항에 있어서, 상기의 투여량이 약 0.3ml에서 약 0.7ml인 것을 특징으로 하는 방법.
- 제17항에 있어서, 상기의 투여가 장내 투여인 것을 특징으로 하는 방법.
- 제25항에 있어서, 상기의 투여량이 약 0.1ml에서 약 2.5ml인 것을 특징으로 하는 방법.
- 제25항에 있어서, 상기의 투여량이 약 0.2ml에서 약 1.0ml인 것을 특징으로 하는 방법.
- 제25항에 있어서, 상기의 투여량이 약 0.3ml에서 약 0.7ml인 것을 특징으로 하는 방법.※ 참고사항 : 최초출원내용에 의하여 공개하는 것임.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86272086A | 1986-05-13 | 1986-05-13 | |
US862720 | 1986-05-13 | ||
US4843587A | 1987-05-11 | 1987-05-11 | |
US048435 | 1987-05-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
KR880013565A true KR880013565A (ko) | 1988-12-21 |
Family
ID=26726121
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019870006798A KR880013565A (ko) | 1986-05-13 | 1987-07-01 | 네리움(Nerium)종의 추출물 및 그것을 이용한 세포-분열 증식 질병의 치료방법 |
Country Status (14)
Country | Link |
---|---|
US (1) | US5135745A (ko) |
JP (1) | JPS6322025A (ko) |
KR (1) | KR880013565A (ko) |
CN (1) | CN87104312A (ko) |
AU (1) | AU626516B2 (ko) |
CA (1) | CA1299100C (ko) |
DK (1) | DK239687A (ko) |
FI (1) | FI872106A (ko) |
IL (1) | IL82516A0 (ko) |
IN (1) | IN165073B (ko) |
MC (1) | MC1811A1 (ko) |
NO (1) | NO871978L (ko) |
NZ (1) | NZ220295A (ko) |
PT (1) | PT84857B (ko) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100478146B1 (ko) * | 2002-08-30 | 2005-03-22 | 재단법인 포항산업과학연구원 | 협죽도과 식물의 잎 추출물을 함유하는 고려잔디갈색퍼짐병 방제용 조성물 및 이를 이용하여 갈색퍼짐병을방제하는 방법 |
Families Citing this family (32)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2003227319B2 (en) * | 1998-09-24 | 2007-07-26 | Ozelle Pharmaceuticals, Inc. | Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof |
JP2002526452A (ja) | 1998-09-24 | 2002-08-20 | オゼル・ファーマスーティカルズ・インコーポレイテッド | キョウチクトウ抽出物、その医薬組成物及びその調整方法 |
US20050112059A1 (en) * | 2003-10-06 | 2005-05-26 | Phoenix Biotechnology, Inc. | Enhancement of radiotherapy by an exogenous cardiac glycoside |
US20050250709A1 (en) * | 2003-12-19 | 2005-11-10 | Bionaut Pharmaceuticals | Anti-neoplastic agents, combination therapies and related methods |
JP2005289963A (ja) * | 2004-03-12 | 2005-10-20 | Hokubu Norin Koto Gakko Koenkai | 抗腫瘍剤 |
US20080027010A1 (en) * | 2004-09-02 | 2008-01-31 | Bionaut Pharmaceuticals, Inc. | Treatment of refractory cancers using Na+/K+-ATPase inhibitors |
US20060135468A1 (en) * | 2004-09-02 | 2006-06-22 | Bionaut Pharmaceuticals, Inc. | Treatment of refractory cancers using NA+/K+ ATPase inhibitors |
US20070105790A1 (en) * | 2004-09-02 | 2007-05-10 | Bionaut Pharmaceuticals, Inc. | Pancreatic cancer treatment using Na+/K+ ATPase inhibitors |
US20060135442A1 (en) * | 2004-09-02 | 2006-06-22 | Bionaut Pharmaceuticals, Inc. | Pancreatic cancer treatment using Na+/K+ ATPase inhibitors |
US20060135441A1 (en) * | 2004-09-02 | 2006-06-22 | Bionaut Pharmaceuticals, Inc. | Combinatorial chemotherapy treatment using Na+/K+ ATPase inhibitors |
EP1812010A2 (en) * | 2004-10-18 | 2007-08-01 | BTG International Limited | Use of na+/ k+-atpase inhibitors and antagonists thereof |
US20060188536A1 (en) * | 2005-02-15 | 2006-08-24 | Phoenix Biotechnology Inc. | Particles from processing of oleander leaves |
JP2007008879A (ja) * | 2005-06-30 | 2007-01-18 | Yanbaru Green Health:Kk | 抗腫瘍剤及びこれを含有する食品 |
US7402325B2 (en) * | 2005-07-28 | 2008-07-22 | Phoenix Biotechnology, Inc. | Supercritical carbon dioxide extract of pharmacologically active components from Nerium oleander |
EP1803461A1 (en) * | 2005-12-27 | 2007-07-04 | Heinz-Herbert Fiebig | Therapeutic use of an extract from the leaves of Nerium oleander |
WO2008078362A1 (ja) * | 2006-12-22 | 2008-07-03 | The Institute Of Biological Resources | 抗腫瘍剤及びこれを含有する食品 |
US8486465B1 (en) * | 2007-07-09 | 2013-07-16 | Douglas CRAWFORD | Therapeutic nerium oleander extract compositions and methods of using |
CN101613414B (zh) * | 2008-06-26 | 2011-09-07 | 中国科学院上海药物研究所 | 两种夹竹桃寡糖及其制备方法和用途 |
WO2010045243A1 (en) * | 2008-10-14 | 2010-04-22 | Nerium Biotechnology, Inc. | Process for extracting cardiac glycodides and compositions |
CN101416988B (zh) * | 2008-12-07 | 2011-12-21 | 中国热带农业科学院热带生物技术研究所 | 采食长春花叶的夹竹桃天蛾幼虫粪便提取物在制备抗肿瘤药物中的用途 |
TR200900312A2 (tr) * | 2009-01-15 | 2010-08-23 | Levent Baş Ahmet | Nerium oleander'in tip II diyabet, obezite, yüksek kolesterol ve trigliserid düzeyi ile seyreden hastalıklar ve kardiovasküler hastalıklarda kullanımı@ |
AU2012325819B2 (en) | 2011-10-20 | 2017-08-03 | Nerium Biotechnology, Inc. | Therapeutic combination for the treatment of cancer |
US10596186B2 (en) | 2016-09-14 | 2020-03-24 | Phoenix Biotechnology, Inc. | Method and compositions for treating viral infections |
US10729735B1 (en) | 2016-09-14 | 2020-08-04 | Phoenix Biotechnology, Inc. | Method and compostitions for treating coronavirus infection |
WO2018053123A1 (en) | 2016-09-14 | 2018-03-22 | Phoenix Biotechnology, Inc. | Method and compositions for treating viral infection |
US10702567B2 (en) | 2016-09-14 | 2020-07-07 | Phoenix Biotechnology, Inc. | Method and compositions for treating viral infection |
EP3681508A4 (en) | 2017-09-14 | 2021-05-19 | Phoenix Biotechnology, Inc. | METHOD AND COMPOSITION FOR THE TREATMENT OF VIRAL INFECTION |
EP4009981B1 (en) | 2020-03-31 | 2023-08-16 | Phoenix Biotechnology, Inc. | Method and compositions for treating coronavirus infection |
US11806359B2 (en) | 2020-03-31 | 2023-11-07 | Phoenix Biotechnology, Inc. | Method and compositions for treating Coronavirus infection |
CA3091376C (en) * | 2020-03-31 | 2023-09-19 | Phoenix Biotechnology, Inc. | Method and compositions for treating coronavirus infection |
CN114209711A (zh) * | 2020-03-31 | 2022-03-22 | 菲尼克斯生物技术公司 | 用于治疗冠状病毒感染的方法和组合物 |
SG11202105728YA (en) | 2020-03-31 | 2021-11-29 | Phoenix Biotechnology Inc | Method and compositions for treating coronavirus infection |
-
1987
- 1987-05-12 PT PT84857A patent/PT84857B/pt not_active IP Right Cessation
- 1987-05-12 DK DK239687A patent/DK239687A/da not_active Application Discontinuation
- 1987-05-12 CA CA000536799A patent/CA1299100C/en not_active Expired - Lifetime
- 1987-05-12 MC MC871885A patent/MC1811A1/xx unknown
- 1987-05-12 IN IN344/MAS/87A patent/IN165073B/en unknown
- 1987-05-12 FI FI872106A patent/FI872106A/fi not_active Application Discontinuation
- 1987-05-13 AU AU72785/87A patent/AU626516B2/en not_active Expired
- 1987-05-13 NO NO871978A patent/NO871978L/no unknown
- 1987-05-13 IL IL82516A patent/IL82516A0/xx unknown
- 1987-05-13 JP JP62116678A patent/JPS6322025A/ja active Granted
- 1987-05-13 CN CN198787104312A patent/CN87104312A/zh active Pending
- 1987-05-13 NZ NZ220295A patent/NZ220295A/en unknown
- 1987-07-01 KR KR1019870006798A patent/KR880013565A/ko not_active Application Discontinuation
-
1990
- 1990-08-24 US US07/572,848 patent/US5135745A/en not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR100478146B1 (ko) * | 2002-08-30 | 2005-03-22 | 재단법인 포항산업과학연구원 | 협죽도과 식물의 잎 추출물을 함유하는 고려잔디갈색퍼짐병 방제용 조성물 및 이를 이용하여 갈색퍼짐병을방제하는 방법 |
Also Published As
Publication number | Publication date |
---|---|
DK239687D0 (da) | 1987-05-12 |
CA1299100C (en) | 1992-04-21 |
IL82516A0 (en) | 1987-11-30 |
AU7278587A (en) | 1987-11-19 |
FI872106A (fi) | 1987-11-14 |
MC1811A1 (fr) | 1988-03-18 |
US5135745A (en) | 1992-08-04 |
NO871978D0 (no) | 1987-05-13 |
PT84857A (en) | 1987-06-01 |
JPS6322025A (ja) | 1988-01-29 |
DK239687A (da) | 1987-11-14 |
FI872106A0 (fi) | 1987-05-12 |
PT84857B (pt) | 1990-02-08 |
CN87104312A (zh) | 1988-01-13 |
JPH0529332B2 (ko) | 1993-04-30 |
AU626516B2 (en) | 1992-08-06 |
NZ220295A (en) | 1990-04-26 |
IN165073B (ko) | 1989-08-12 |
NO871978L (no) | 1987-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR880013565A (ko) | 네리움(Nerium)종의 추출물 및 그것을 이용한 세포-분열 증식 질병의 치료방법 | |
Barre et al. | Studies on the physiology of secretin: III. Further studies on the effects of secretin on the blood sugar | |
Goldhaber | Osteogenic induction across millipore filters in vivo | |
DE3132656A1 (de) | Zedrachrindenextrakt mit antineoplastischer wirkung | |
Aptekman et al. | A method of producing in inbred albino rats a high percentage of immunity from tumors native in their strain | |
Bhatti et al. | Ethnobotany of Calotropis procera with special reference to the people of Nara Desert | |
Venkataramana et al. | Anti-inflammatory potential of ethanolic extracts from aerial parts of Ipomoea pes-caprae (L.) R. Br using cotton pellet induced granuloma model | |
CN111803531A (zh) | 一种蒲公英叶水溶性粗提物的制备方法及其应用 | |
CN107753531B (zh) | 文王一支笔提取物及其在制备抗癌药物中的应用 | |
GB1430885A (en) | Process for preparing a purified extract of quillaia bark | |
CN102477041A (zh) | 一种盐酸千金藤素的制备方法 | |
Noble et al. | Some unusual findings on the carcinogenic action of urethane in mice | |
Penttilä et al. | Binding of 1-3, 4-dihydroxyphenylalanine and dopamine in cytoplasmic granules of paneth cells | |
RU2792434C1 (ru) | Способ получения органо-минерального препарата с росторегулирующими и фунгицидными свойствами | |
KR20040036992A (ko) | 흰점박이꽃무지 유충으로부터 조추출물을 추출하는 방법및 그 조추출물을 유효성분으로 함유하는 당뇨질환 치료용약학적 조성물 | |
CN108484373A (zh) | 一个具有促胶原蛋白分泌功效的化合物及其应用 | |
Tanaka | Mechanism of antitumor action of polysaccharide fraction prepared from bagasse. I | |
Tsao et al. | A note on the biological activity of root extracts from Pleiocarpa mutica Benth.(Apocynaceae) | |
KR100254946B1 (ko) | 천화분 수추출엑기스의 제조 방법 및 이를 함유한 소염진통제 조성물 | |
JPS61200923A (ja) | 抗アレルギ−作用を有する物質とその製造方法 | |
RU2624861C2 (ru) | Нуфлеин бисангидрохлорид, обладающий цитотоксической активностью по отношению к опухолевым клеткам человека | |
DE1667884C3 (de) | Verfahren zur Gewkinung von reinem Ae sein | |
SU457476A1 (ru) | Способ получени суммы флавоноидов, обладающих гиипоазотемическим действием | |
DE718245C (de) | Verfahren zur Bestimmung des Vorhandenseins boesartiger Geschwuelste | |
DE1617566C (de) | Verfahren zur Herstellung eines physio logisch aktiven Polypeptide |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |